Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


ALKERMES reported $25.82M in Pre-Tax Profit for its fiscal quarter ending in December of 2022.

Pre Tax Profit Change
AbbVie ABBV:US USD 5.08B 2.33B
Acadia Pharmaceuticals ACAD:US USD -44939000 4.05M
Bluebird Bio BLUE:US USD 21.24M 11.1M
Coherus Biosciences CHRS:US USD -75729000 16.86M
Intra Cellular Therapies ITCI:US USD -44043000 17K
Ionis Pharmaceuticals IONS:US USD -113000000 81M
J&J JNJ:US USD 8.47B 1.05B
Marinus Pharmaceuticals MRNS:US USD -34730000 2.05M
Merck & Co MRK:US USD 4.48B 411M
Minerva Neurosciences NERV:US USD -6970000 244K
Nektar Therapeutics NKTR:US USD -137081000 80.54M
Neurocrine Biosciences NBIX:US USD -103300000 221.2M
Otsuka Holdings 4578:JP JPY 79.24B 52.29B
Revance Therapeutics RVNC:US USD -59793000 86.16M